EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Germline Variants in Patients with Hereditary Cancer Syndromes in Northeast Mexico

Diana Cristina Pérez-Ibave, María Lourdes Garza-Rodríguez iD, María Fernanda Noriega-Iriondo, Sonia María Flores-Moreno, Manuel Ismael González-Geroniz, Absalon Espinoza-Velazco, Ana Lilia Castruita-Ávila, Fernando Alcorta-Núñez iD, Omar Alejandro Zayas-Villanueva, Juan Francisco González-Guerrero, Adelina Alcorta-Garza iD, Oscar Vidal-Gutiérrez und 1 weitere

Genes · 2023

DOI: 10.3390/genes14020341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Diana Cristina Pérez-Ibave und 12 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Oncología, Centro Universitario Contra el Cáncer (CUCC), Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nu…. Hauptthemen laut MEDLINE: Genetic Testing, Neoplastic Syndromes, Hereditary. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CECIL and public and private donations, National Institute of Cancerology A.C..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary cancer syndromes (HCS) are genetic diseases with an increased risk of developing cancer. This research describes the implementation of a cancer prevention model, genetic counseling, and germline variants testing in an oncologic center in Mexico. A total of 315 patients received genetic counseling, genetic testing was offered, and 205 individuals were tested for HCS. In 6 years, 131 (63.90%) probands and 74 (36.09%) relatives were tested. Among the probands, we found that 85 (63.9%) had at least one germline variant. We identified founder mutations in BRCA1 and a novel variant in APC that led to the creation of an in-house detection process for the whole family. The most frequent syndrome was hereditary breast and ovarian cancer syndrome (HBOC) (41 cases with BRCA1 germline variants in most of the cases), followed by eight cases of hereditary non-polyposic cancer syndrome (HNPCC or Lynch syndrome) (with MLH1 as the primarily responsible gene), and other high cancer risk syndromes. Genetic counseling in HCS is still a global challenge. Multigene panels are an essential tool to detect the variants frequency. Our program has a high detection rate of probands with HCS and pathogenic variants (40%), compared with other reports that detect 10% in other populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingNeoplastic Syndromes, HereditaryFemaleHumansMexicoGerm-Line MutationGerm Cells

Stichwörter der Autor:innen

genetic counselinghereditary cancer syndromespathogenic variants

Autor:innen und Institutionen

  • Servicio de Oncología, Centro Universitario Contra el Cáncer (CUCC), Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey 66451, Nuevo León, Mexico.
  • Hospital Regional de Alta Especialidad Materno-Infantil, Guadalupe 67140, Nuevo León, Mexico.
  • Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado (ISSSTE), Hospital Regional de Monterrey, Monterrey 64380, Nuevo León, Mexico.
  • Centro Médico Nacional Noreste, Instituto Mexicano del Seguro Social (IMSS), Unidad Médica de Alta Especialidad (UMAE) No. 25, Monterrey 64180, Nuevo León, Mexico.
  • ONCARE Treatment Center, Valle Unit, San Pedro Garza Garcia 66220, Nuevo Leon, Mexico.
  • Instituto Mexicano del Seguro Social (IMSS), Unidad Médica de Alta Especialidad, Hospital de Gineco Obstetricia (HGO) No. 23, Monterrey 64000, Nuevo León, Mexico.

ORCID-Profile: María Lourdes Garza-Rodríguez, Fernando Alcorta-Núñez, Adelina Alcorta-Garza, Carlos Horacio Burciaga-Flores

Förderung

  • CECIL and public and private donations
  • National Institute of Cancerology A.C.

Zitieren

APA

Pérez-Ibave, D. C., Garza-Rodríguez, M. L., Noriega-Iriondo, M. F., Flores-Moreno, S. M., González-Geroniz, M. I., Espinoza-Velazco, A., Castruita-Ávila, A. L., Alcorta-Núñez, F., Zayas-Villanueva, O. A., González-Guerrero, J. F., Alcorta-Garza, A., Vidal-Gutiérrez, O., & Burciaga-Flores, C. H. (2023). Identification of Germline Variants in Patients with Hereditary Cancer Syndromes in Northeast Mexico. Genes. https://doi.org/10.3390/genes14020341

Vancouver

Pérez-Ibave DC, Garza-Rodríguez ML, Noriega-Iriondo MF, Flores-Moreno SM, González-Geroniz MI, Espinoza-Velazco A, et al. Identification of Germline Variants in Patients with Hereditary Cancer Syndromes in Northeast Mexico. Genes. 2023. doi:10.3390/genes14020341

BibTeX
@article{PrezIbave2023,
  author = {Pérez-Ibave, Diana Cristina and Garza-Rodríguez, María Lourdes and Noriega-Iriondo, María Fernanda and Flores-Moreno, Sonia María and González-Geroniz, Manuel Ismael and Espinoza-Velazco, Absalon and Castruita-Ávila, Ana Lilia and Alcorta-Núñez, Fernando and Zayas-Villanueva, Omar Alejandro and González-Guerrero, Juan Francisco and Alcorta-Garza, Adelina and Vidal-Gutiérrez, Oscar and Burciaga-Flores, Carlos Horacio},
  title = {Identification of Germline Variants in Patients with Hereditary Cancer Syndromes in Northeast Mexico},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14020341}
}
Kostenlos starten →